pharmacy

Disease-modifying Drug Safety and Effectiveness in Multiple Sclerosis [DRUMS]

British Columbia (BC) and Canada have some of the world's highest rates of multiple sclerosis (MS). The goal of this research is to find out how safe and effective the drugs used to treat MS are when used in the everyday, real world in BC and Canada.

Primary Investigator: 
Award Type: 
Year: 
2019

Implementation and evaluation of an enhanced PharmaNet-based adverse drug event reporting platform to improve patient safety and meet adverse drug reaction reporting requirements

MSFHR is contributing match-funding towards Dr. Ellen Balka’s research (co-led with Dr. Corinne Hohl, recent awardee of Clinician Scientist Award), one of 22 projects as part of the Canadian Institutes for Health Research (CIHR) eHealth Innovation Partnership Program (eHIPP). eHIPP was designed to address gaps in health care — including supporting seniors with complex care needs in their home — by stimulating collaborations between health researchers and Canadian innovative technology companies.

Primary Investigator: 
Award Type: 
Year: 
2015

Implementing and evaluating ActionADE to transform medication safety

Medications have transformed the lives of Canadians suffering from many debilitating conditions. However, medications may also cause harm. As medication use has increased, so has the incidence of adverse drug events (ADEs), harmful and unintended events related to medication use. Today, ADEs cause over 2 million emergency department visits across Canada each year, and are a leading cause of admissions. 

Preventing ADEs is not easy. Health care providers often unknowingly expose patients to the same or similar medications as ones that previously caused harm. For example: 

Primary Investigator: 
Year: 
2018

Optimizing lifestyle approaches for the prevention and treatment of type 2 diabetes

The rising incidence of type 2 diabetes (T2D) puts financial stress on health care systems in British Columbia and across the world. Lifestyle interventions can improve cardiometabolic health to prevent or treat T2D, but optimal lifestyle strategies (e.g. exercise intensity, type, timing; diet composition) are not well-defined and adherence is notoriously poor.

Primary Investigator: 
Award Type: 
Year: 
2017
Health Category: 

A multi-centre 2x2 factorial randomized trial comparing sliding hip screws versus cancellous screws and vitamin D versus placebo on patient-important complications and quality of life in the treatment of young adult (ages 18-60) femoral neck fractures

Unlike elderly hip fractures that are commonly treated with a joint replacement, young patients are typically treated with surgical fixation devices to facilitate fracture healing, preserve the native hip, and allow for higher functional demands. Unfortunately, approximately 20% of these patients experience significant fracture healing complications and an additional 30% heal their fracture in a non-anatomic position that negatively affects their function.

Primary Investigator: 
Award Type: 
Year: 
2014
Subscribe to RSS - pharmacy